Business Wire

Calvin Klein, Inc. Chief Creative Officer Raf Simons Collaborates with The xx for “I Dare You” Music Video

29.6.2017 16:00 | Business Wire

Jaa

Calvin Klein, Inc. today announced that Chief Creative Officer Raf Simons collaborated with The xx and photographer and filmmaker Alasdair McLellan on the creative concept and direction for the music video for the band’s latest song “I Dare You.”

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170629005144/en/

Calvin Klein, Inc. Chief Creative Officer Raf Simons Collaborates with The xx for “I Dare You” Music ...

Calvin Klein, Inc. Chief Creative Officer Raf Simons Collaborates with The xx for “I Dare You” Music Video (Photo: © 2017 Alasdair McLellan)

Simons has had a longstanding appreciation of The xx – Jamie Smith, Romy Madley Croft and Oliver Sim – and was drawn to the band’s work with McLellan on the music videos for “On Hold” and “Say Something Loving.” Seeing a connection between the videos and his own work at CALVIN KLEIN, Simons was pleased to collaborate on the third video of the trilogy, lending his eye to the architectural and atmospheric elements and utilizing an eclectic cast of CALVIN KLEIN collaborators.

The music video, which was filmed in Los Angeles at Lloyd Wright’s Sowden house and John Lautner’s Rainbow House, opens with actress Millie Bobby Brown, who currently appears in the Calvin Klein By Appointment campaign, and also features Ashton Sanders, currently featured in the men’s Spring 2017 Calvin Klein Underwear advertising campaign; Paris Jackson, who attended this year’s Costume Institute Benefit as a guest of the brand; and models Lulu and Ernesto Cervantes, who each appear in advertising campaigns for the brand as well as the Fall 2017 CALVIN KLEIN 205W39NYC runway show.

The video debuts today on The xx’s YouTube channel. For more information on the collaboration, please click here.

About PVH Corp.

With a history going back over 135 years, PVH has excelled at growing brands and businesses with rich American heritages, becoming one of the largest apparel companies in the world. We have over 35,000 associates operating in over 40 countries and over $8 billion in annual revenues. We own the iconic CALVIN KLEIN , Tommy Hilfiger , Van Heusen , IZOD , ARROW , Speedo*, Warner’s and Olga brands, and market a variety of goods under these and other nationally and internationally known owned and licensed brands.

*The Speedo brand is licensed for North America and the Caribbean in perpetuity from Speedo International, Limited.

EDITORIAL CREDIT: CALVIN KLEIN

IMAGE CREDITS: © 2017 Alasdair McLellan

TO VIEW VIDEO: https://www.youtube.com/watch?v=qqflFMhkqHM&feature=youtu.be

SOCIAL MEDIA: facebook.com/calvinklein ; calvinklein.tumblr.com ; google.com/+calvinklein ; youtube.com/calvinklein ; twitter.com/calvinklein ; instagram.com/calvinklein ; pinterest.com/calvinklein
snapchat: calvinklein
brand handle: @calvinklein

Contact information

Calvin Klein, Inc.
Alexandra Wagner, 212-292-9794
SVP, Corporate Communications
alexandrawagner@ck.com
or
Amanda Peña, Director, 212-292-9223
Corporate Communications
amandapena@ck.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Major Terrorist Plot Foiled in Saudi Arabia, Ministry of Interior Announces21.7.2017 21:33Tiedote

The following is a statement from Saudi Arabia’s Ministry of Culture and Information: This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170721005575/en/ Weapons and other items found in the possession of the three terrorists are an indication of the ugliness and severity of the acts of terrorism they were planning to carry out, victimizing innocent lives and private and public property. (Photo: ME NewsWire) The Saudi Ministry of Interior has announced that a major terrorist attack was prevented by security services in the city of Saihat in the Qatif governorate. On the evening of Friday, July 14th, security services intercepted a stolen Toyota Corolla vehicle in a busy, built-up district of the city. As the stolen vehicle was surrounded by security services, three men in the ca

Janssen Receives Positive CHMP Opinion for SYMTUZA™ The First Darunavir-Based Single-Tablet Regimen for the Treatment of HIV21.7.2017 15:09Tiedote

Janssen-Cilag International NV (Janssen) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for SYMTUZA™ (darunavir/cobicistat/emtricitabine/tenofovir alafenamide [D/C/F/TAF]), a once-daily darunavir-based single tablet regimen (STR). If approved, it will be the only darunavir-based STR indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents aged 12 years and older with body weight of at least 40 kg, with genotypic testing guiding use. This STR combines the proven efficacy and durability of darunavir with the improved renal laboratory and bone mineral density profile of F/TAF as compared to F/TDF (tenofovir disoproxil fumarate), and will be the only treatment that could deliver the adherence advantag

Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (Telotristat Ethyl), for the Treatment of Carcinoid Syndrome Diarrhea in Patients Inadequately Controlled by Somatostatin Analogue Therapy21.7.2017 14:26Tiedote

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has adopted a positive opinion recommending the approval of Xermelo® (telotristat ethyl) 250 mg three times a day (tid) for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analogue (SSA) therapy in adults inadequately controlled by SSA therapy. The CHMP positive opinion will now be reviewed by the European Commission (EC), which has the authority to approve medicines for use in the 28 countries of the European Union, as well as Norway, Liechtenstein and Iceland. David Meek, Chief Executive Officer of Ipsen, said: “The positive CHMP opinion for Xermelo ® is an important milestone towards providing innovative s

NRI Secure Launches Japan's First "Blockchain Assessment" Service21.7.2017 10:00Tiedote

NRI SecureTechnologies, Ltd. (President: Jun Odashima; hereinafter NRI Secure), a leading provider of information security solutions in Japan, has begun providing Japan’s first-ever*1 “Blockchain Assessment,” a security Assessment service designed for systems and services which use blockchain technology*2. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170721005012/en/ Overview of the "Blockchain Assessment" Service (Graphic: Business Wire) As the blockchain technology has become more widespread, the presence of security-related vulnerabilities has also become increasingly apparent. In particular, with regard to smart contracts, *3 one of a constituent element of services using the blockchain, a cyberattack carried out on any vulnerable programs could lead to major threats or eve

Business Figures for the First Half of 2017: Sartorius Continues to Grow21.7.2017 08:00Tiedote

Sartorius (FWB:SRT), a leading international laboratory and pharmaceutical equipment supplier, continues on the growth track. In the first half of 2017, solid organic business development and two acquisitions led to a significant increase in sales revenue and earnings1. "Sartorius has continued its dynamic, profitable development," said CEO and Executive Board Chairman Dr. Joachim Kreuzburg in commenting on the company's first-half performance. "Both divisions achieved solid organic growth in an environment that was especially challenging in North America, and have made quick progress in integrating the businesses most recently acquired. In the Lab Products & Services Division, the bioanalytics unit newly created by our acquisitions has already contributed significant revenues and earnings. We see further considerable growth potential ahead for this business just as for the

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme